Vivelle (estradiol transdermal system)
/ Sanofi, Hisamitsu, Novartis
- LARVOL DELTA
Home
Next
Prev
1 to 9
Of
9
Go to page
1
January 17, 2025
Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder
(clinicaltrials.gov)
- P4 | N=30 | Not yet recruiting | Sponsor: Mahidol University
New P4 trial • Overactive Bladder
November 07, 2024
Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women
(clinicaltrials.gov)
- P4 | N=86 | Completed | Sponsor: Mahidol University | Active, not recruiting ➔ Completed
Trial completion • Overactive Bladder • Urinary Incontinence • Urology
July 18, 2024
Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women: A Randomized Controlled Study
(clinicaltrials.gov)
- P4 | N=86 | Active, not recruiting | Sponsor: Mahidol University
New P4 trial • Overactive Bladder • Urinary Incontinence • Urology
February 27, 2024
Drugs for menopausal symptoms.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal
January 26, 2021
CRM010: Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion
(clinicaltrials.gov)
- P1; N=10; Recruiting; Sponsor: University of Virginia; Not yet recruiting ➔ Recruiting; Initiation date: Oct 2020 ➔ Feb 2021
Enrollment open • Trial initiation date • Polycystic Ovary Syndrome
October 22, 2020
CRM010: Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion
(clinicaltrials.gov)
- P1; N=10; Not yet recruiting; Sponsor: University of Virginia
New P1 trial • Polycystic Ovary Syndrome
September 23, 2020
Drugs for menopausal symptoms.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal
August 06, 2019
Estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms.
(PubMed, Med Lett Drugs Ther)
- No abstract available.
Journal
August 06, 2019
Colorectal cancer screening.
(PubMed, Med Lett Drugs Ther)
- No abstract available.
Journal
1 to 9
Of
9
Go to page
1